Veracyte

VCYT NASDAQ
28.56
+0.99
+3.59%
已收盘, 16:48 06/17 EDT
开盘
27.83
昨收
27.57
最高
28.90
最低
27.31
成交量
66.84万
成交均量(3M)
69.22万
52周最高
28.90
52周最低
8.48
换手率
1.42%
市值
13.43亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Veracyte VCYT股票价格,Veracyte股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Veracyte, Inc. is a genomic diagnostics company. The Company uses genomic technology to resolve diagnostic ambiguity. It targets diseases in which patients undergo invasive diagnostic procedures. Its products combine genomic technology, clinical science and machine learning. The Company commercializes over three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. The Company’s commercial solution, the Afirma Thyroid fine needle aspiration (FNA) Analysis, centers on the Afirma Gene Expression Classifier (GEC). The Afirma GEC is offered directly or as part of a solution that also includes cytopathology. The Company operates in the pulmonology diagnostics market. It offers Percepta Bronchial Genomic Classifier, a genomic test to resolve ambiguity in lung cancer diagnosis. It also offers the Envisia Genomic Classifier, which is designed to help in the assessment of patients suspected to have idiopathic pulmonary fibrosis.
展开 >

最近浏览

名称
价格
涨跌幅